PC
BIIB icon

Paulson & Co’s Biogen BIIB Stock Holding History

Paulson & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17,300
Closed -$4.73M – 112
2017
Q1 		$4.73M Sell
17,300
-34,900
-67% -$9.87M 0.06% 74
2016
Q4 		$14.8M Sell
52,200
-255,800
-83% -$75.8M 0.19% 58
2016
Q3 		$96.4M Buy
308,000
+184,900
+150% +$54.8M 1.04% 20
2016
Q2 		$29.8M Buy
123,100
+4,700
+4% +$1.24M 0.3% 43
2016
Q1 		$30.8M Buy
118,400
+82,200
+227% +$21.7M 0.23% 46
2015
Q4 		$11.1M Buy
+36,200
New +$10.4M 0.07% 49

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paulson & Co's BIIB Position: Q2 2017 in Review

Paulson & Co sold out of Biogen (BIIB) in Q2 2017, closing a stake of 17,300 shares — an estimated $4.73M sold.

Paulson & Co first reported a position in BIIB in Q4 2015 and held it in 6 quarters. The position peaked at $96.4M in Q3 2016. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Paulson & Co reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Paulson & Co sold 17,300 Biogen shares in Q2 2017, an estimated $4.73M.
  • Paulson & Co first reported a position in Biogen in Q4 2015 and held it in 6 quarters.
  • Paulson & Co's Biogen position peaked at $96.4M in Q3 2016.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Paulson & Co's 13F filing for Q2 2017, filed 14 Aug 2017.